title: Antiplatelet combinations for prevention of atherothrombotic events.
abstract: Antiplatelet therapy plays a fundamental role in reducing atherothrombotic events by several pathways. The present work reviews available evidence on antiplatelet therapy both for primary prevention and in the presence of established peripheral, cerebral, or cardiac ischemic disease. Due to the importance of adherence to therapy to achieve optimal effects, special attention is given to the use of fixed-dose oral formulations in the clinical subset of patients in whom double antiplatelet therapy has proven indications.
authors.affiliation: Department of Internal Medicine, Division of Cardiology, University of Torino, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Bollati
authors.forename: Fiorenzo
authors.initials: F
authors.lastname: Gaita
authors.forename: Matteo
authors.initials: M
authors.lastname: Anselmino
mesh_terms: D004338:Drug Combinations; D019317:Evidence-Based Medicine; D006801:Humans; D015539:Platelet Activation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011322:Primary Prevention / Q000379:methods*; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention / Q000379:methods*; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D004338:Drug Combinations; D010975:Platelet Aggregation Inhibitors